Fractyl Health (GUTS) Capital Expenditures (2023 - 2025)
Fractyl Health (GUTS) reported Capital Expenditures of $3000.0 for Q4 2025, down 98.71% year-on-year from $233000.0 in Q4 2024, and down 62.5% quarter-over-quarter from $8000.0 in Q3 2025.
Fractyl Health (GUTS) has 3 years of Capital Expenditures data on file, last reported at $3000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Expenditures fell 98.71% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2025 stood at $557000.0 (down 68.44% YoY), and the FY2025 full-year result was $557000.0, down 68.44% from the prior year.
- Capital Expenditures for Q4 2025 stood at $3000.0, down from $8000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.3 million in Q2 2024 and bottomed at -$54000.0 in Q3 2023.
- A 3-year average of $201083.3 and a median of $62500.0 in 2023 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 2261.82% in 2024 and tumbled 98.71% in 2025, its largest moves.
- Tracing GUTS's Capital Expenditures over 3 years: stood at $70000.0 in 2023, then surged by 232.86% to $233000.0 in 2024, then tumbled by 98.71% to $3000.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $3000.0, $8000.0, and $98000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 230.60 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Mar 31, 2025 | 448,000.00 |
| Mar 31, 2025 | 448,000.00 |
| Dec 31, 2024 | 233,000.00 |
| Dec 31, 2024 | 233,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Dec 31, 2023 | 70,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |